GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Cash Flow for Dividends

A Plus Biotechnology Co (ROCO:6918) Cash Flow for Dividends : NT$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Cash Flow for Dividends?

A Plus Biotechnology Co's cash flow for dividends for the three months ended in Dec. 2024 was NT$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

A Plus Biotechnology Co's annual payment of dividends increased from Dec. 2022 (NT$-15.2 Mil) to Dec. 2023 (NT$-21.1 Mil) and increased from Dec. 2023 (NT$-21.1 Mil) to Dec. 2024 (NT$-81.5 Mil).

A Plus Biotechnology Co Cash Flow for Dividends Historical Data

The historical data trend for A Plus Biotechnology Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Cash Flow for Dividends Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial - -14.32 -15.24 -21.13 -81.49

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

A Plus Biotechnology Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A Plus Biotechnology Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Cash Flow for Dividends
Comparable Companies
ROCO:4138 TPE:6955 TPE:6796 TPE:4155 ROCO:7713 ROCO:6747 TPE:6861 TPE:4106 ROCO:6934 ROCO:6815 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
Website
https://www.aplusbio.com
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines